Investigations of tablets prepared from pellets produced by extrusion and spheronisation Part I: The application of canonical analysis to correlate the properties of the tablets to the factors studied in combination with principal component analysis to select the most relevant factors-Reference-Cited by-同舟云学术

Investigations of tablets prepared from pellets produced by extrusion and spheronisation Part I: The application of canonical analysis to correlate the properties of the tablets to the factors studied in combination with principal component analysis to select the most relevant factors

Published:1997-02 Issue:1 Volume:147 Page:79-93
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Pinto J.F.,Podczeck F.,Newton J.M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Causes of tablet compression problems;Armstrong;Manuf. Chem.,1982

2. The strength and compaction of millispheres;Aulton;Drug Dev. Ind. Pharm.,1994

3. The statistical significance of canonical correlations;Bartlett;Biometrika,1941

4. Controlled-release multipleunits and single-units doses;Bechgaard,1978

5. Preparation of small solid pharmaceutical spheres;Conine;Drug Cosmet. Ind.,1970

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cushion-coated pellets for tableting without external excipients;International Journal of Pharmaceutics;2024-03

2. The Common Approaches to Study Compaction Process of Pharmaceutical Powders;Advanced Materials Research;2014-10

3. Application of Principal Component Analysis (PCA) to Evaluating the Deformation Behaviors of Pharmaceutical Powders;Journal of Pharmaceutical Innovation;2013-04-25

4. Understanding deformation mechanisms during powder compaction using principal component analysis of compression data;International Journal of Pharmaceutics;2011-10

5. A flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS);Journal of Controlled Release;2010-10-01